PepGen Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020
Cash & Equivalents	80.77	181.75	132.9	9.78
Short-Term Investments	29.63	0	0	0
Cash & Cash Equivalents	110.41	181.75	132.9	9.78
Cash Growth	-39.25%	36.76%	1259.12%	-
Receivables	0	0	4.74	0.41
Other Current Assets	2.27	4.33	2.35	0.13
Total Current Assets	112.68	186.08	139.99	10.32
Property, Plant & Equipment	28.38	29.88	0.64	0.32
Other Long-Term Assets	1.99	1.47	3.02	0
Total Long-Term Assets	30.37	31.36	3.66	0.32
Total Assets	143.05	217.44	143.64	10.64
Accounts Payable	1.01	1.36	3.24	0.72
Current Debt	3	5.55	0	0
Other Current Liabilities	13.52	11.91	7.08	0.12
Total Current Liabilities	17.53	18.83	10.32	0.84
Long-Term Debt	17.1	18.98	0	0
Other Long-Term Liabilities	0	0	0.23	0.03
Total Long-Term Liabilities	17.1	18.98	0.23	0.03
Total Liabilities	34.63	37.81	10.55	0.87
Total Debt	20.1	24.53	0	0
Debt Growth	-18.06%	-	-	-
Retained Earnings	-181.48	-102.86	-33.75	-6.47
Comprehensive Income	0.03	-0.08	0.02	-0.01
Shareholders' Equity	108.42	179.63	-32.08	-6.36
Net Cash / Debt	90.3	157.22	132.9	9.78
Net Cash / Debt Growth	-42.56%	18.30%	1259.12%	-
Net Cash Per Share	3.79	10.05	147.48	11.24
Working Capital	95.15	167.26	129.67	9.48
Book Value Per Share	4.56	11.49	-35.60	-7.31

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).